A Multi-Phase and Multiple Site Clinical Trial Management Organization
Excellence in Patient Care
An Awarded Team
Scala Clinical Research is deeply involved in helping chronic patients by getting access to newest therapies as soon as possible.
We are aware of the rapid development of new therapies and the rising number of clinical studies.
For us the patient comes first.
Scala Clinical Research is dedicated to the highest quality of clinical trials, determined to bring the newest possibilities in modern medicine closer by the patients .Our internal standards are attentively monitored in order to on the highest quality of our trial delivery.Combining the focus of an independent network of research sites with premium clinical trial expertise, Scala Clinical Research provides patients, CROs and Sponsors a complete range of high medical services: fast site agreement, trial implementation, site initiation, fulfilled enrollments and excellent retention rates.
The well grounded career of our PIs, SIs and SCs, integrated with their medical competencies help promise our patients will be given the most professional and watchful level of clinical trials.
RESEARCH MEDICINE UNITS
Scala Clinical Research is a Site Management Organization administering its own network of clinical trials centers and principal investigators. We are the leading Romanian provider for clinical research services providing the entire portfolio of specific clinical trial services for Sponsors and Clinical Research Organizations.Each of our units is entirely designed for clinical trials.
Please find more about our units.
Currently our business is conducted in 3 main units inside Medlife Grivita, MedLife Titan, and Clinical Hsopital CF2 – all of them in Bucharest, the capital of Romania
Scientific/Medical support for protocol development
Our professional certifications make us eligible to take responsibility for many types of clinical trials. The notable qualifications of our physicians and study coordinators, associated with their medical capabilities, help assuring a top standard in clinical trials.
Our experience spreads across clinical trials phases I-IV in, immuno-inflammatory diseases, oncology, cardiovascular, diabetes/metabolic, respiratory, hepatology, nephrology, gastroenterology, infectious diseases HCV/HIV, urology, oncology, dermatology, neurology, psychiatry, ophthalmology.
Scala Clinical Research has a dedicated department of experienced specialists in charge for patients recruitment and patients care.
The success of our recruitment is based on our permanent attention and dedication to the patient.
For each clinical trial, based on our long term experience, we develop a characteristic recruitment process. This process is designed by our expert colleagues after a detailed analysis of the clinical trial protocol. The recruitment flow and the design of the recruitment activities are particularly cut for meeting the patient profile. Our focus is to fulfill patient expectations, to move away the patient worries and in the same time to succeed in reach the medical requirements of Sponsor or CRO.
Our recruitment department is specialized in recruitment process design, recruitment flow deployment, recruitment completion, study presentation methodology, prescreening and patient navigation.
Scala’s recruitment department focuses very precise on the initial recruitment assesment with Sponsors and CROs for the met recruitment rates.
Experience Our Advance Facilities
Scala Clinical Research is deeply involved in helping chronic patients by getting access to newest therapies as soon as possible. Focus for patient care is defining us.
We are aware of the rapid development of new therapies and the rising number of clinical studies. And we know the success of each clinical trial is inconceivable to be fulfilled without our committed MDs and colleagues.
With over 20 years of experience, Scala Clinical Research deploys numerous clinical trials, at high standards of operations, compliance and data quality, delivering results within agreed financial and time constraints.